citalopram has been researched along with Affective Psychosis, Bipolar in 87 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "83 weeks) in patients with unipolar depression (studies=4, n=187; monotherapy vs lithium=1, augmentation of antidepressants vs placebo=3) or bipolar depression (studies=14, n=1965; monotherapy vs placebo=5, monotherapy vs lithium or olanzapine+fluoxetine=2, augmentation of antidepressants vs placebo=1, augmentation of mood stabilizers vs placebo=3, augmentation of mood stabilizers vs trancylpromine, citalopram, or inositol=3) were meta-analyzed." | 8.93 | Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. ( Anghelescu, IG; Correll, CU; Gao, K; Normann, C; Reis, C; Schaffer, A; Solmi, M; van der Loos, ML; Veronese, N; Zaninotto, L, 2016) |
| "The aim of this study was to compare the outcomes of monotherapy in individuals with bipolar disorder who are prescribed lithium, valproate, quetiapine, olanzapine, venlafaxine, or citalopram in private psychiatric practices in Germany." | 8.02 | Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram. ( Bauer, M; Bohlken, J; Kostev, K; Riedel-Heller, S, 2021) |
| " The first reported case of quetiapine and citalopram-associated serotonin syndrome is discussed with reference to a Medline, Embase, and PsycINFO literature search." | 7.73 | Quetiapine and citalopram: aetiological significances in serotonin syndrome. ( Marlowe, K; Schirgel, D, 2006) |
| "The present paper describes a case of serotonin syndrome (SS), which developed in a patient with bipolar affective disorder after the addition of olanzapine to her regimen of lithium and citalopram." | 7.71 | Can olanzapine be implicated in causing serotonin syndrome? ( Haslett, CD; Kumar, S, 2002) |
| "Between 2007 and 2014, 119 subjects with acute major depressive episodes diagnosed with DSM-IV bipolar disorder, type I or type II, were randomized blindly to citalopram or placebo, added to standard mood stabilizers." | 5.41 | Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD): A Randomized, Double-Blind, Placebo-Controlled Trial. ( Amerio, A; Barroilhet, SA; Ghaemi, SN; Patkar, AA; Sverdlov, O; Vohringer, PA; Whitham, EA, 2021) |
| " This study is the first to analyze blood levels of the pro-inflammatory biomarker C-reactive protein (CRP) in bipolar disorder patients treated with the cyclooxygenase-2 inhibitor, celecoxib (CBX)." | 5.27 | Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. ( Edberg, D; Fareed, J; Halaris, A; Hoppensteadt, D; Sinacore, J; Walborn, A, 2018) |
| " In the present work we studied for the first time the dose-dependent changes of ECG, body surface potential maps (BSPM - parameter DIAM 30, 40) in 43 TCA dosulepine, 40 SSRI citalopram and 30 Li outpatients (Hamilton scale: HAMDŁ10; age 40+/-5 years; treated for depressive disorders or bipolar disorders)." | 5.10 | Electrocardiographic dose-dependent changes in prophylactic doses of dosulepine, lithium and citalopram. ( Dohnalová, A; Kitzlerová, E; Paclt, I; Pisvejcová, K; Slavícek, J, 2003) |
| " They also suggest that lithium for comorbid bipolar disorder, escitalopram for comorbid anxiety disorders, and the addition of CBT to standard drug treatment for comorbid schizophrenia may be effective." | 4.93 | Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research. ( Dowling, NA; Lorains, FK; Merkouris, SS, 2016) |
| "83 weeks) in patients with unipolar depression (studies=4, n=187; monotherapy vs lithium=1, augmentation of antidepressants vs placebo=3) or bipolar depression (studies=14, n=1965; monotherapy vs placebo=5, monotherapy vs lithium or olanzapine+fluoxetine=2, augmentation of antidepressants vs placebo=1, augmentation of mood stabilizers vs placebo=3, augmentation of mood stabilizers vs trancylpromine, citalopram, or inositol=3) were meta-analyzed." | 4.93 | Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. ( Anghelescu, IG; Correll, CU; Gao, K; Normann, C; Reis, C; Schaffer, A; Solmi, M; van der Loos, ML; Veronese, N; Zaninotto, L, 2016) |
| "The aim of this study was to compare the outcomes of monotherapy in individuals with bipolar disorder who are prescribed lithium, valproate, quetiapine, olanzapine, venlafaxine, or citalopram in private psychiatric practices in Germany." | 4.02 | Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram. ( Bauer, M; Bohlken, J; Kostev, K; Riedel-Heller, S, 2021) |
| " Here we present a case of a young adult suffering from bipolar disorder who used a combination of two SSRIs (citalopram and fluoxetine) and a monoamine oxidase inhibitor (MAO; moclobemide) with tragic consequences." | 3.88 | Fatal intoxication with antidepressants: a case with many culprits. ( Goulas, A; Krokos, D; Mastrogianni, O; Orphanidis, A; Raikos, N; Tsepa, A; Zisopoulos, K, 2018) |
| "We evaluated treatment response and covariates in 82 depressed patients diagnosed with DSM-IV major depressive (n=50) or bipolar disorders (n=32) treated initially in a day-hospital for 2 weeks, followed by 4 weeks of outpatient treatment, using citalopram given intravenously and then orally, with or without a mood-stabilizer." | 3.76 | Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients. ( Baldessarini, RJ; De Pisa, E; Girardi, P; Innamorati, M; Pompili, M; Tatarelli, R; Tondo, L, 2010) |
| "An open, multi-centre study was designed to address the effectiveness and tolerability profile of treatment with escitalopram under naturalistic conditions, in elderly outpatients (above 65 years of age) with depression." | 3.76 | Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany. ( Flürenbrock, W; Möller, HJ; Schnitker, J, 2010) |
| "Two cases, one of recurrent depression and another of major depressive disorder with hypertension switched to hypomania while on escitalopram." | 3.75 | Hypomania induced by escitalopram: 2 case reports. ( Sharma, RC, 2009) |
| " The first reported case of quetiapine and citalopram-associated serotonin syndrome is discussed with reference to a Medline, Embase, and PsycINFO literature search." | 3.73 | Quetiapine and citalopram: aetiological significances in serotonin syndrome. ( Marlowe, K; Schirgel, D, 2006) |
| "In order to evaluate the effect of treatment with citalopram (CIT) and lithium (Li) on hormone levels in women with bipolar disorder, morning plasma prolactin (PRL) and cortisol (CORT) were measured in 14 nonmedicated depressed patients, 13 depressed patients responding to CIT treatment, 17 euthymic patients on long-term Li treatment, and 11 healthy controls." | 3.72 | Decreased plasma prolactin release in euthymic lithium-treated women with bipolar disorder. ( Aberg-Wistedt, A; El Khoury, A; Mathé, AA; Stain-Malmgren, R; Tham, A, 2003) |
| "A 47-year-old white man with a history of bipolar disorder was being maintained on citalopram 40 mg once daily and zolpidem 5 mg at bedtime." | 3.72 | Somnambulism due to probable interaction of valproic acid and zolpidem. ( Bhatia, SC; Petty, F; Ramaswamy, S; Sattar, SP, 2003) |
| "The present paper describes a case of serotonin syndrome (SS), which developed in a patient with bipolar affective disorder after the addition of olanzapine to her regimen of lithium and citalopram." | 3.71 | Can olanzapine be implicated in causing serotonin syndrome? ( Haslett, CD; Kumar, S, 2002) |
| "The increased VEGF in bipolar depression agrees with similar findings in major depressive disorder." | 2.94 | Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction. ( Castillo, MFR; Cohen, A; Edberg, D; Fareed, J; Halaris, A; Hoppensteadt, D; Martin, B, 2020) |
| "Escitalopram was given at a dose of 10 mg per day for 3 weeks and 20 mg per day thereafter." | 2.84 | Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression. ( Aparicio, LVM; Benseñor, IM; Borrione, L; Brunoni, AR; Chamorro, R; Fernandes, RA; Fraguas, R; Fregni, F; Gattaz, WF; Lotufo, PA; Moffa, AH; Moreno, ML; Nogueira, BS; Razza, LB; Sampaio-Junior, B; Tort, LC; Veronezi, BP, 2017) |
| "Open treatment with citalopram followed by up to 3 sequential next-step treatments." | 2.76 | Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. ( Fava, M; Goldberg, JF; Ostacher, M; Perlis, RH; Rush, AJ; Trivedi, MH; Uher, R, 2011) |
| "Patients (N = 27) with major depressive disorder received a standard antidepressant treatment (Venlafaxine, Escitalopram) plus flexible dose of quetiapine." | 2.73 | Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression. ( Baune, BT; Caliskan, S; Todder, D, 2007) |
| "Escitalopram was associated with significant improvement as measured by the HAM-D total score, which showed a mean reduction from baseline (mean = 20." | 2.72 | An open trial of adjunctive escitalopram in bipolar depression. ( Fonseca, M; Hatch, JP; Kapczinski, F; Santin, AP; Soares, JC, 2006) |
| "These findings suggest that in bipolar depression anger attacks are common, may respond favorably to acute treatment with citalopram added to mood stabilizer, and are better predicted by trait anger than hypomanic or depressive symptoms." | 2.71 | Anger attacks in bipolar depression: predictors and response to citalopram added to mood stabilizers. ( Chengappa, KN; Kupfer, DJ; Mammen, OK; Pilkonis, PA, 2004) |
| "Three cases of patients presenting a substance use disorder with comorbid major depression episodes are presented, who were treated with a reboxetine/escitalopram combination and who showed a rapid response of their depressive syndrome." | 2.71 | Escitalopram/reboxetine combination in depressed patients with substance use disorder. ( Camarasa, X; Duboc, A; Khazaal, Y; Lopez-Martinez, E; Zullino, DF, 2005) |
| "The citalopram-treated patients in whom AAM developed were significantly older than those in whom it did not (about 10 years, P < 0." | 2.69 | Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients? ( Barak, Y; Kimhi, R; Weizman, R, 2000) |
| "Discontinuation or withdrawal symptoms have been documented for all major classes of antide- pressants, especially the selective serotonin reuptake inhibitors (SSRIs)." | 1.40 | Emerging mania following escitalopram withdrawal in a patient with unipolar depression managed with its reintroduction. ( DE Berardis, D; DI Giannantonio, M; Fornaro, M; Kahn, DA; Marini, S; Martinotti, G; Serroni, N; Valchera, A, 2014) |
| "Bipolar disorder; migraines and epilepsy are three prevalent conditions, of which little is understood about their pathophysiological processes." | 1.38 | Case report of a patient with bipolar disorder - migraines and epilepsy. ( Agius, M; Zaman, R; Zhang, C, 2012) |
| "Escitalopram (ESC) is a novel selective serotonin reuptake inhibitor that seems to have a favorable side effect profile." | 1.35 | The safety of the electroconvulsive therapy-escitalopram combination. ( Florakis, A; Markatou, M; Masdrakis, VG; Oulis, P; Papadimitriou, GN; Valamoutopoulos, T, 2008) |
| "The treatment of bipolar depression remains a major clinical challenge." | 1.31 | Citalopram as adjunctive therapy in bipolar depression. ( Chengappa, KN; Gelenberg, AJ; Goldberg, JF; Grochocinski, VJ; Hirschfeld, RM; Houck, PR; Kolar, AB; Kupfer, DJ; Sachs, GS, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.15) | 18.7374 |
| 1990's | 7 (8.05) | 18.2507 |
| 2000's | 41 (47.13) | 29.6817 |
| 2010's | 30 (34.48) | 24.3611 |
| 2020's | 8 (9.20) | 2.80 |
| Authors | Studies |
|---|---|
| Strawbridge, R | 1 |
| Kurana, S | 1 |
| Kerr-Gaffney, J | 1 |
| Jauhar, S | 1 |
| Kaufman, KR | 1 |
| Yalin, N | 1 |
| Young, AH | 1 |
| Halaris, A | 4 |
| Cantos, A | 1 |
| Johnson, K | 1 |
| Hakimi, M | 1 |
| Sinacore, J | 2 |
| Murata, S | 1 |
| Murphy, M | 1 |
| Hoppensteadt, D | 3 |
| Fareed, J | 3 |
| Welborn, A | 1 |
| Castillo, MFR | 1 |
| Cohen, A | 1 |
| Edberg, D | 2 |
| Martin, B | 1 |
| Ghaemi, SN | 3 |
| Whitham, EA | 1 |
| Vohringer, PA | 1 |
| Barroilhet, SA | 1 |
| Amerio, A | 2 |
| Sverdlov, O | 1 |
| Patkar, AA | 1 |
| Goldberg, JF | 3 |
| Bohlken, J | 1 |
| Riedel-Heller, S | 1 |
| Bauer, M | 1 |
| Kostev, K | 1 |
| Sretavan Wong, K | 1 |
| Migó, M | 1 |
| Dougherty, DD | 1 |
| Brunoni, AR | 1 |
| Moffa, AH | 1 |
| Sampaio-Junior, B | 1 |
| Borrione, L | 1 |
| Moreno, ML | 1 |
| Fernandes, RA | 1 |
| Veronezi, BP | 1 |
| Nogueira, BS | 1 |
| Aparicio, LVM | 1 |
| Razza, LB | 1 |
| Chamorro, R | 1 |
| Tort, LC | 1 |
| Fraguas, R | 1 |
| Lotufo, PA | 1 |
| Gattaz, WF | 1 |
| Fregni, F | 1 |
| Benseñor, IM | 1 |
| Kwok, CSN | 1 |
| Lim, LEC | 1 |
| Goulas, A | 1 |
| Raikos, N | 1 |
| Krokos, D | 1 |
| Mastrogianni, O | 1 |
| Orphanidis, A | 1 |
| Zisopoulos, K | 1 |
| Tsepa, A | 1 |
| Walborn, A | 1 |
| Abou Kassm, S | 1 |
| Naja, W | 1 |
| Abeysundera, H | 1 |
| Gill, R | 1 |
| Vijay, A | 1 |
| Becker, JE | 1 |
| Ross, JS | 1 |
| Jha, MK | 1 |
| Malchow, AL | 1 |
| Grannemann, BD | 1 |
| Rush, AJ | 3 |
| Trivedi, MH | 3 |
| Yoon, W | 1 |
| Shon, SH | 1 |
| Hong, Y | 1 |
| Joo, YH | 1 |
| Lee, JS | 1 |
| Kluge, M | 1 |
| Dietzel, J | 1 |
| Nowidi, K | 1 |
| Kunisch, R | 1 |
| Bouna-Pyrrou, P | 1 |
| Meißner, D | 1 |
| Hennig-Fast, K | 1 |
| Weindl, A | 1 |
| Förster, S | 1 |
| Neuhann, TM | 1 |
| Falkai, P | 1 |
| Berger, M | 1 |
| Musil, R | 1 |
| Lu, YY | 1 |
| Hsueh, JH | 1 |
| Wei, IH | 1 |
| Huang, CC | 1 |
| Ugurlu, TT | 1 |
| Acar, G | 1 |
| Karadag, F | 1 |
| Acar, F | 1 |
| DE Berardis, D | 1 |
| Serroni, N | 1 |
| Marini, S | 1 |
| Fornaro, M | 1 |
| Valchera, A | 1 |
| Martinotti, G | 1 |
| DI Giannantonio, M | 1 |
| Kahn, DA | 1 |
| Kogoj, A | 1 |
| Hayashi, A | 1 |
| Le Gal, K | 1 |
| Södersten, K | 1 |
| Vizlin-Hodzic, D | 1 |
| Ågren, H | 1 |
| Funa, K | 1 |
| Ansermot, N | 1 |
| Chocron, O | 1 |
| Herrera, F | 1 |
| Eap, CB | 1 |
| Chen, LF | 1 |
| Chi, HC | 1 |
| Lin, CE | 1 |
| Tonna, M | 1 |
| Odone, A | 1 |
| Stubbs, B | 1 |
| Dowling, NA | 1 |
| Merkouris, SS | 1 |
| Lorains, FK | 1 |
| Solmi, M | 1 |
| Veronese, N | 1 |
| Zaninotto, L | 1 |
| van der Loos, ML | 1 |
| Gao, K | 1 |
| Schaffer, A | 2 |
| Reis, C | 1 |
| Normann, C | 1 |
| Anghelescu, IG | 1 |
| Correll, CU | 1 |
| Masdrakis, VG | 1 |
| Oulis, P | 1 |
| Florakis, A | 1 |
| Valamoutopoulos, T | 1 |
| Markatou, M | 1 |
| Papadimitriou, GN | 1 |
| Michael, N | 1 |
| Pfleiderer, B | 1 |
| Arora, M | 1 |
| Praharaj, SK | 1 |
| Sinha, VK | 2 |
| Sarkar, S | 1 |
| Sharma, RC | 1 |
| Pompili, M | 1 |
| Baldessarini, RJ | 1 |
| Tondo, L | 1 |
| Innamorati, M | 1 |
| Tatarelli, R | 1 |
| Girardi, P | 1 |
| De Pisa, E | 1 |
| Todder, D | 2 |
| Caliskan, S | 2 |
| Baune, BT | 2 |
| Quante, A | 1 |
| Zeugmann, S | 1 |
| Luborzewski, A | 1 |
| Schommer, N | 1 |
| Langosch, J | 1 |
| Born, C | 1 |
| Anghelescu, I | 1 |
| Wolf, J | 1 |
| Davis, A | 1 |
| Gilhooley, M | 1 |
| Agius, M | 2 |
| Zaman, R | 2 |
| Rabasseda, X | 1 |
| Möller, HJ | 1 |
| Schnitker, J | 1 |
| Flürenbrock, W | 1 |
| Perlis, RH | 2 |
| Uher, R | 1 |
| Ostacher, M | 1 |
| Fava, M | 2 |
| Cusin, C | 1 |
| Zhang, C | 1 |
| Diler, RS | 1 |
| Ladouceur, CD | 1 |
| Segreti, A | 1 |
| Almeida, JR | 1 |
| Birmaher, B | 1 |
| Axelson, DA | 1 |
| Phillips, ML | 1 |
| Pan, LA | 1 |
| Haslett, CD | 1 |
| Kumar, S | 1 |
| Dean, B | 1 |
| Scarr, E | 1 |
| Pavey, G | 1 |
| Copolov, D | 1 |
| Paclt, I | 1 |
| Slavícek, J | 1 |
| Dohnalová, A | 1 |
| Kitzlerová, E | 1 |
| Pisvejcová, K | 1 |
| El Khoury, A | 1 |
| Tham, A | 1 |
| Mathé, AA | 1 |
| Aberg-Wistedt, A | 1 |
| Stain-Malmgren, R | 1 |
| Sattar, SP | 1 |
| Ramaswamy, S | 1 |
| Bhatia, SC | 1 |
| Petty, F | 1 |
| Ameen, S | 1 |
| Jagadheesan, K | 1 |
| Bobo, WV | 1 |
| Grammer, GG | 1 |
| Mammen, OK | 1 |
| Pilkonis, PA | 1 |
| Chengappa, KN | 2 |
| Kupfer, DJ | 3 |
| Duggal, HS | 2 |
| Gates, C | 1 |
| Pathak, PC | 1 |
| Pravin, D | 1 |
| Srinath, S | 1 |
| Girimaji, S | 1 |
| Seshadri, SP | 1 |
| Prapotnik, M | 1 |
| Di Pauli, J | 1 |
| Vetter, Z | 1 |
| König, P | 1 |
| Conca, A | 2 |
| Waschgler, R | 1 |
| Bies, RR | 1 |
| Feng, Y | 1 |
| Lotrich, FE | 1 |
| Kirshner, MA | 1 |
| Roose, S | 1 |
| Pollock, BG | 1 |
| Hausmann, A | 1 |
| Kramer-Reinstadler, K | 1 |
| Lechner-Schoner, T | 1 |
| Walpoth, M | 1 |
| Rupp, CI | 1 |
| Hinterhuber, H | 1 |
| Benazzi, F | 2 |
| Camarasa, X | 1 |
| Lopez-Martinez, E | 1 |
| Duboc, A | 1 |
| Khazaal, Y | 1 |
| Zullino, DF | 1 |
| Dunner, DL | 1 |
| Fonseca, M | 1 |
| Soares, JC | 1 |
| Hatch, JP | 1 |
| Santin, AP | 1 |
| Kapczinski, F | 1 |
| Parker, G | 1 |
| Tully, L | 1 |
| Olley, A | 1 |
| Hadzi-Pavlovic, D | 1 |
| Hazen, C | 1 |
| Goldberger, C | 1 |
| Zuker, P | 1 |
| Levitt, A | 1 |
| Marlowe, K | 1 |
| Schirgel, D | 1 |
| Castberg, I | 1 |
| Spigset, O | 1 |
| Grover, S | 1 |
| Biswas, P | 1 |
| Bhateja, G | 1 |
| Kulhara, P | 1 |
| McLean, RM | 1 |
| Harrison-Woolrych, M | 1 |
| Mendhekar, DN | 1 |
| Wickham, R | 1 |
| Varma, A | 1 |
| Nierenberg, AA | 1 |
| Alpert, JE | 1 |
| Gaynes, BN | 1 |
| Warden, D | 1 |
| Wisniewski, SR | 1 |
| Biggs, MM | 1 |
| Barkin, JL | 1 |
| Rocha, FF | 1 |
| Correa, H | 1 |
| Lage, NV | 1 |
| Kul, M | 1 |
| Kilincaslan, A | 1 |
| Yumru, M | 1 |
| Kandemir, H | 1 |
| Adaletli, H | 1 |
| Ceylan, MF | 1 |
| Lejoyeux, M | 1 |
| Daniels, JP | 1 |
| Felde, A | 1 |
| Ropert, R | 1 |
| Lôo, H | 2 |
| Gay, C | 1 |
| Seifritz, E | 1 |
| Hatzinger, M | 1 |
| Müller, MJ | 1 |
| Hemmeter, U | 1 |
| Holsboer-Trachsler, E | 1 |
| Bryois, C | 1 |
| Ferrero, F | 1 |
| Berk, M | 1 |
| Koopowitz, LF | 1 |
| Szabo, CP | 1 |
| Voegeli, J | 1 |
| Baumann, P | 1 |
| Vesely, C | 1 |
| Fischer, P | 1 |
| Goessler, R | 1 |
| Kasper, S | 1 |
| Barak, Y | 1 |
| Kimhi, R | 1 |
| Weizman, R | 1 |
| Goodnick, PJ | 1 |
| Gelenberg, AJ | 1 |
| Hirschfeld, RM | 1 |
| Sachs, GS | 1 |
| Grochocinski, VJ | 1 |
| Houck, PR | 1 |
| Kolar, AB | 1 |
| Leake, A | 1 |
| Fairbairn, AF | 1 |
| McKeith, IG | 1 |
| Ferrier, IN | 1 |
| Vanelle, JM | 1 |
| Poirier, MF | 1 |
| Benkelfat, C | 1 |
| Galinowski, A | 1 |
| Sechter, D | 1 |
| Suzini de Luca, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression: Role of Inflammation and Kynurenine Pathway Biomarkers[NCT01479829] | Phase 4 | 88 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram[NCT00562861] | Phase 2/Phase 3 | 119 participants (Actual) | Interventional | 2007-11-30 | Completed | ||
| Escitalopram and Transcranial Direct Current Stimulation in Major Depressive Disorder: a Double-blind, Placebo-controlled, Randomized, Non-inferiority Trial[NCT01894815] | Phase 3 | 245 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| Psychological Interventions and Transcranial Direct Current Stimulation for the Treatment of Major Depressive Disorder[NCT04889976] | 210 participants (Actual) | Interventional | 2021-05-22 | Completed | |||
| The DiSCoVeR Project: Examining the Synergistic Effects of a Cognitive Control Videogame and a Self-administered Non-invasive Brain Stimulation on Alleviating Depression[NCT04953208] | 114 participants (Anticipated) | Interventional | 2021-06-22 | Recruiting | |||
| Home-based Transcranial Direct Current Stimulation in Postpartum Depression: the Feasibility Study and Pilot Study[NCT05046405] | 50 participants (Anticipated) | Interventional | 2022-10-02 | Not yet recruiting | |||
| Assessment of Efficacy and Safety of Anodal Transcranial Direct Current Stimulation (TDCS) in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemics[NCT04780152] | Phase 2/Phase 3 | 172 participants (Anticipated) | Interventional | 2021-10-31 | Recruiting | ||
| TBS Treatment for Treatment-Resistant Depression: a Randomized, Sham-Controlled Trial[NCT05388539] | 100 participants (Anticipated) | Interventional | 2022-06-06 | Recruiting | |||
| An Open Label Home-administered Transcranial Direct Current Stimulation (tDCS) Clinical Trial of Unipolar Depression[NCT04781127] | Phase 1 | 50 participants (Actual) | Interventional | 2021-02-10 | Completed | ||
| The BrainDrugs-Epilepsy Study: A Prospective Open-label Cohort Precision Medicine Study in Epilepsy[NCT05450822] | 550 participants (Anticipated) | Observational | 2022-02-18 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Montgomery Asberg Depression Rating scale assessed in mixed effects regression model. The total range for the scale is 0 to 60. Lower values involve less depression, while higher values involve worse depression. The change in the MADRS scale is interpreted as higher values meaning better outcomes, because more depressive symptoms are improved. (NCT00562861)
Timeframe: 6 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| Citalopram | 13.1 |
| Placebo | 15.2 |
6 reviews available for citalopram and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
A systematic review and meta-analysis of treatments for rapid cycling bipolar disorder.
Topics: Aripiprazole; Bipolar Disorder; Citalopram; Fluoxetine; Humans; Lamotrigine; Olanzapine; Quetiapine | 2022 |
Mania following antidepressant discontinuation in depression: two case reports.
Topics: Aged; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Bipolar Diso | 2017 |
Selective serotonin reuptake inhibitors-induced delirium: a case review.
Topics: Aged; Aged, 80 and over; Bipolar Disorder; Citalopram; Delirium; Dose-Response Relationship, Drug; D | 2014 |
Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research.
Topics: Acetylcysteine; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Bipolar | 2016 |
Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Topics: Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bip | 2016 |
[Compulsive buying: psychological and biological treatment].
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Citalopram; Commerce; Compulsive Behavior; Depressiv | 2007 |
21 trials available for citalopram and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Modulation of the inflammatory response benefits treatment-resistant bipolar depression: A randomized clinical trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Bipolar Disorder; Celecoxib; | 2020 |
Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depression.
Topics: Bipolar Disorder; Celecoxib; Citalopram; Depressive Disorder, Treatment-Resistant; Humans; Interleuk | 2020 |
Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Celecoxib; Cita | 2020 |
Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD): A Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Acute Disease; Adolescent; Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalo | 2021 |
Neural correlates of citalopram and placebo response in acute bipolar depression: A randomized trial.
Topics: Bipolar Disorder; Citalopram; Depression; Double-Blind Method; Humans; Placebo Effect; Selective Ser | 2021 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Bipolar Disorder; Citalopram; Dep | 2017 |
Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Body Mass Index; C-Reactive | 2018 |
Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Bipolar Disorder; Bupropion; Citalopram; Depressive D | 2018 |
Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antimanic Agents; Aripiprazole; Bipolar Disor | 2010 |
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Citalopram; Depressive Disorder, Major; Female; Humans; M | 2011 |
Electrocardiographic dose-dependent changes in prophylactic doses of dosulepine, lithium and citalopram.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antide | 2003 |
Anger attacks in bipolar depression: predictors and response to citalopram added to mood stabilizers.
Topics: Adult; Anger; Anticonvulsants; Bipolar Disorder; Citalopram; Drug Therapy, Combination; Female; Huma | 2004 |
Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects.
Topics: Administration, Oral; Adult; Aged; Algorithms; Bipolar Disorder; Black People; Blood Specimen Collec | 2004 |
Escitalopram/reboxetine combination in depressed patients with substance use disorder.
Topics: Adult; Alcoholism; Antidepressive Agents; Bipolar Disorder; Citalopram; Depressive Disorder, Major; | 2005 |
An open trial of adjunctive escitalopram in bipolar depression.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Citalopram; Drug Therapy, Combination; Female; Humans; Lit | 2006 |
SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Citalopram; Cross-Over Studies; Depressive Disorder, Majo | 2006 |
Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder | 2006 |
Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Arousal; Bipolar Disorder; Circadian Rhyth | 2007 |
Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
Topics: Adult; Age of Onset; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Cogniti | 2008 |
Is selectivity for serotonin uptake associated with a reduced emergence of manic episodes in depressed patients?
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopr | 2000 |
Diagnostic and therapeutic value of testing stimulation of thyroid-stimulating hormone by thyrotropin-releasing hormone in 100 depressed patients.
Topics: Adult; Aged; Bipolar Disorder; Citalopram; Depressive Disorder; Female; Humans; Male; Maprotiline; M | 1990 |
60 other studies available for citalopram and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
How Much Is the Debate Over Antidepressant Efficacy and Safety in Bipolar Depression an Artifact of Study Methodologies?
Topics: Antidepressive Agents; Artifacts; Bipolar Disorder; Citalopram; Double-Blind Method; Humans | 2021 |
Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram.
Topics: Antipsychotic Agents; Bipolar Disorder; Citalopram; Humans; Lithium; Olanzapine; Quetiapine Fumarate | 2021 |
Fatal intoxication with antidepressants: a case with many culprits.
Topics: Adult; Bipolar Disorder; Cardiomyopathy, Hypertrophic; Citalopram; Fluoxetine; Genotype; Heterozygot | 2018 |
Looking for bipolarity in antidepressant discontinuation manic states: Update and diagnostic considerations of the phenomenon.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bipolar Disorder; Child; Citalopram; Cyclothy | 2018 |
Possible SAMe-induced mania.
Topics: Adult; Bipolar Disorder; Citalopram; Depression; Drug Therapy, Combination; Female; Hallucinations; | 2018 |
Patterns and predictors of off-label prescription of psychiatric drugs.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Citalopram; Cross-Sectional Studies; Drug Presc | 2018 |
Antidepressant Prescription Patterns in Bipolar Disorder: a Nationwide, Register-based Study in Korea.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Anxiety Disor | 2018 |
Substantial weight gain associated with severe carbohydrate craving in a patient receiving quetiapine.
Topics: Antipsychotic Agents; Bipolar Disorder; Citalopram; Dibenzothiazepines; Dietary Carbohydrates; Eatin | 2013 |
[The White man's burden - a case study caught between bipolar affective disorder and Huntington's disease].
Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Citalopram; Dibenzothiazepines; Femal | 2013 |
Delirium caused by a drug-drug interaction between bupropion and risperidone.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bipolar Disorder; Bupropion; Citalop | 2014 |
Manic episode following deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a case report.
Topics: Antiparkinson Agents; Anxiety; Bipolar Disorder; Citalopram; Deep Brain Stimulation; Electrodes, Imp | 2014 |
Emerging mania following escitalopram withdrawal in a patient with unipolar depression managed with its reintroduction.
Topics: Adult; Bipolar Disorder; Citalopram; Depressive Disorder; Female; Humans; Psychiatric Status Rating | 2014 |
Calcium-dependent intracellular signal pathways in primary cultured adipocytes and ANK3 gene variation in patients with bipolar disorder and healthy controls.
Topics: Adipocytes; Adult; Ankyrins; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Dis | 2015 |
Severe manic episode associated with tramadol in a patient with recurrent depressive disorder.
Topics: Analgesics, Opioid; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents | 2015 |
Hyponatremia masquerading as panic symptoms in bipolar affective disorder.
Topics: Aged; Anti-Anxiety Agents; Bipolar Disorder; Citalopram; Estazolam; Female; Humans; Hyponatremia; Pa | 2014 |
Treatment of comorbid bipolar disorder and anxiety disorders: A great challenge to modern psychiatry.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Comorbidity; Humans; Mal | 2016 |
The safety of the electroconvulsive therapy-escitalopram combination.
Topics: Aged; Bipolar Disorder; Citalopram; Combined Modality Therapy; Depressive Disorder, Major; Electroco | 2008 |
Primary onset of bipolar disorder as rapid cycling after cessation of oral contraceptive.
Topics: Adult; Ambulatory Care; Bipolar Disorder; Citalopram; Contraceptives, Oral; Depressive Disorder, Maj | 2009 |
Schizencephaly associated with bipolar II disorder.
Topics: Bipolar Disorder; Brain; Citalopram; Depression; Diagnosis, Differential; Dibenzothiazepines; Humans | 2009 |
Hypomania induced by escitalopram: 2 case reports.
Topics: Adult; Aged; Bipolar Disorder; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; | 2009 |
Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Dis | 2010 |
Longitudinal changes of day-time and night-time gross motor activity in clinical responders and non-responders of major depression.
Topics: Actigraphy; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Circadian Rh | 2009 |
Suicide risk and choice of antidepressant.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Community Mental Heal | 2010 |
A report from the 4th biennial conference of the international society of bipolar disorder (March 17-20, 2010 - Sao Paulo, Brazil).
Topics: Bipolar Disorder; Brazil; Citalopram; Dopamine Antagonists; Haloperidol; Humans; Selective Serotonin | 2010 |
Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany.
Topics: Aged; Aged, 80 and over; Bipolar Disorder; Citalopram; Dementia; Depression; Depressive Disorder; De | 2010 |
Proposed DSM-5 mixed features are associated with greater likelihood of remission in out-patients with major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Bipolar Disorder; Citalopram; Depressive Disorder, Major; Diagno | 2014 |
Case report of a patient with bipolar disorder - migraines and epilepsy.
Topics: Adult; Affect; Anger; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agent | 2012 |
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Diso | 2013 |
Can olanzapine be implicated in causing serotonin syndrome?
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Female; Humans; Lithium Chlorid | 2002 |
Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder.
Topics: Affinity Labels; Binding Sites; Biomarkers; Bipolar Disorder; Carrier Proteins; Cell Count; Citalopr | 2003 |
Decreased plasma prolactin release in euthymic lithium-treated women with bipolar disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Case-Control Studies; Citalopram; Female; Humans; Hy | 2003 |
Somnambulism due to probable interaction of valproic acid and zolpidem.
Topics: Bipolar Disorder; Citalopram; Depression; Drug Interactions; Drug Therapy, Combination; Humans; Male | 2003 |
Citalopram-induced manic switch in an adolescent with epilepsy.
Topics: Adolescent; Anticonvulsants; Bipolar Disorder; Citalopram; Epilepsy, Generalized; Humans; Male | 2003 |
Escitalopram-associated mania.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Depression; Humans; M | 2003 |
Olanzapine-induced neutropenia: mechanism and treatment.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar | 2004 |
Citalopram and mania.
Topics: Adolescent; Bipolar Disorder; Child; Citalopram; Depressive Disorder; Humans; Male; Selective Seroto | 2004 |
Antidepressant-associated mania with escitalopram.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Citalopram; Depressive Disorder; Humans; Male; Selective S | 2004 |
Can bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) induce mania? A case report.
Topics: Bipolar Disorder; Citalopram; Combined Modality Therapy; Functional Laterality; Humans; Prefrontal C | 2004 |
Anger in depressive mixed states.
Topics: Adult; Anger; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Depressive Dis | 2004 |
Interactive case conference. First episode: depression and panic disorder.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Citalopram; Clonazepam; Depression; | 2005 |
[Bipolar disorder type I].
Topics: Adult; Bipolar Disorder; Citalopram; Humans; Selective Serotonin Reuptake Inhibitors; Severity of Il | 2005 |
Quetiapine and citalopram: aetiological significances in serotonin syndrome.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antipsychotic Agents; Bipolar Disorder; Citalopram; Dibenzot | 2006 |
Excretion of escitalopram in breast milk.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Female; Humans; Infan | 2006 |
Escitalopram-associated hyponatremia.
Topics: Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Citalopram; Electrocardiography; F | 2007 |
Alopecia associated with quetiapine.
Topics: Adult; Affective Disorders, Psychotic; Alopecia; Antipsychotic Agents; Azabicyclo Compounds; Bipolar | 2007 |
A case report of reemergence of antipsychotic-induced dyskinesia with citalopram.
Topics: Antipsychotic Agents; Bipolar Disorder; Citalopram; Dyskinesia, Drug-Induced; Humans; Male; Middle A | 2007 |
Ziprasidone-associated mania in a case of obssessive-compulsive disorder.
Topics: Anticonvulsants; Bipolar Disorder; Citalopram; Clonazepam; Dose-Response Relationship, Drug; Drug In | 2007 |
Behavioral disinhibition without persistent mood elevation after high dose citalopram treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Bipolar Disorder; Citalopram; Depressive Disorder; | 2007 |
Escitalopram-associated mania in a child.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Child; Citalopram; Female; Humans; Selec | 2008 |
Quetiapine treatment for mania secondary to brain injury in 2 patients.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Brain Injuries; Citalopram; Dibenzothiazepines; Drug | 2008 |
[Open preliminary study of new antidepressive compound: citalopram].
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bipolar Disorder; Citalopram; Depressive Disorder; D | 1984 |
Hair loss associated with fluoxetine but not with citalopram.
Topics: Alopecia; Bipolar Disorder; Citalopram; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middl | 1995 |
Mania induced by citalopram.
Topics: Bipolar Disorder; Citalopram; Depressive Disorder; Humans; Male; Middle Aged | 1994 |
Antidepressant induced mania in obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Citalopram; Clomipramine; Female; Fluoxetine; Follow | 1996 |
Inappropriate secretion of antidiuretic hormone and SSRIs.
Topics: Aged; Bipolar Disorder; Citalopram; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; | 1996 |
Mania associated with serotonin selective reuptake inhibitors.
Topics: Bipolar Disorder; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Paroxet | 1997 |
Summary from the 153rd meeting of the American Psychiatric Association. 13-18 May 2000, Chicago, Illinois, USA.
Topics: Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Citalopram; Depressi | 2000 |
Citalopram as adjunctive therapy in bipolar depression.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Citalopram; Drug Therapy, Combination; Female; Humans; Ma | 2001 |
Organic hypomania secondary to sibutramine-citalopram interaction.
Topics: Adult; Appetite Depressants; Bipolar Disorder; Citalopram; Cyclobutanes; Depressive Disorder; Drug I | 2002 |
Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates.
Topics: Adult; Aged; Bipolar Disorder; Brain; Brain Mapping; Citalopram; Depressive Disorder; Dominance, Cer | 1991 |